Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
暂无分享,去创建一个
D. Berman | J. Spertus | P. Hartigan | W. Boden | K. Teo | W. Weintraub | G. Mancini | D. Maron | W. Kostuk | Philip G. Jones | S. Sedlis | Zugui Zhang | Philip G. Jones
[1] S. Thom,et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial , 2018, The Lancet.
[2] Liang Li,et al. Joint multiple imputation for longitudinal outcomes and clinical events that truncate longitudinal follow‐up , 2016, Statistics in medicine.
[3] H. Krumholz,et al. The New Era of Informed Consent: Getting to a Reasonable-Patient Standard Through Shared Decision Making. , 2016, JAMA.
[4] Zhongheng Zhang,et al. Model building strategy for logistic regression: purposeful selection. , 2016, Annals of translational medicine.
[5] D. Kent,et al. Development and validation of a simplified Stroke–Thrombolytic Predictive Instrument , 2015, Neurology.
[6] J. Spertus,et al. Prediction of residual angina after percutaneous coronary intervention. , 2015, European heart journal. Quality of care & clinical outcomes.
[7] J. Spertus,et al. Improving the process of informed consent for percutaneous coronary intervention: patient outcomes from the Patient Risk Information Services Manager (ePRISM) study. , 2015, American heart journal.
[8] Michael E. Matheny,et al. Validated Contemporary Risk Model of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the National Cardiovascular Data Registry Cath‐PCI Registry , 2014, Journal of the American Heart Association.
[9] J. Spertus,et al. Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial , 2014, Circulation. Cardiovascular quality and outcomes.
[10] J. Spertus,et al. Variation in patients’ perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional study , 2014, BMJ : British Medical Journal.
[11] J. Spertus,et al. Development and Validation of a Short Version of the Seattle Angina Questionnaire , 2014, Circulation. Cardiovascular quality and outcomes.
[12] Stephen D. Persell,et al. ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the Amer , 2014, Circulation.
[13] J. Spertus,et al. Derivation and Validation of a Risk Standardization Model for Benchmarking Hospital Performance for Health-Related Quality of Life Outcomes After Acute Myocardial Infarction , 2014, Circulation.
[14] Mandeep Singh,et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. , 2013, JACC. Cardiovascular interventions.
[15] Daniel S Berman,et al. Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial , 2013, Circulation. Cardiovascular quality and outcomes.
[16] Deepak L. Bhatt,et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[17] J. Spertus,et al. Selecting Antiplatelet Therapy at the Time of Percutaneous Intervention for an Acute Coronary Syndrome: Weighing the Benefits and Risks of Prasugrel Versus Clopidogrel , 2013, Circulation. Cardiovascular quality and outcomes.
[18] Sankey V. Williams,et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.
[19] G. Levine,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.
[20] Laura Mauri,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.
[21] Y. Schenker,et al. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. , 2011, Annals of internal medicine.
[22] David M Kent,et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.
[23] Elizabeth R DeLong,et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. , 2010, Journal of the American College of Cardiology.
[24] Harlan M Krumholz,et al. Informed consent to promote patient-centered care. , 2010, JAMA.
[25] D. Berman,et al. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. , 2009, The American journal of cardiology.
[26] Zoran Bursac,et al. Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.
[27] J. Spertus. Evolving Applications for Patient-Centered Health Status Measures , 2008, Circulation.
[28] Gabriel E. Soto,et al. Converting the Informed Consent From a Perfunctory Process to an Evidence-Based Foundation for Patient Decision Making , 2008, Circulation. Cardiovascular quality and outcomes.
[29] Stanley E. Kaufman,et al. Effect of PCI on quality of life in patients with stable coronary disease. , 2008, The New England journal of medicine.
[30] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.
[31] O. Ozkan,et al. Expected treatment benefits of percutaneous transluminal coronary angioplasty: the patient’s perspective , 2008, The International Journal of Cardiovascular Imaging.
[32] Grace A Lin,et al. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. , 2007, Archives of internal medicine.
[33] J. Spertus,et al. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. , 2007, Mayo Clinic proceedings.
[34] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[35] Stanley E. Kaufman,et al. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. , 2006, American heart journal.
[36] D. Berman,et al. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424. , 2006, American heart journal.
[37] David M Kent,et al. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis , 2006, BMC medical research methodology.
[38] J. Ioannidis,et al. Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis , 2005, Circulation.
[39] Randall C. Thompson,et al. Predictors of Quality-of-Life Benefit After Percutaneous Coronary Intervention , 2004, Circulation.
[40] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[41] M. Sculpher,et al. Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. , 2002, European heart journal.
[42] Peter C Austin,et al. A comparison of methods for analyzing health-related quality-of-life measures. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[43] D. Fairclough. Design and analysis of quality of life studies in clinical trials , 2002, Quality of Life Research.
[44] H. Krumholz,et al. Perceptions of benefit and risk of patients undergoing first-time elective percutaneous coronary revascularization , 2000, Journal of General Internal Medicine.
[45] D. Waters,et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.
[46] R. Gibbons,et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review , 1997 .
[47] R A Deyo,et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. , 1995, Journal of the American College of Cardiology.
[48] J. Spertus,et al. Monitoring the quality of life in patients with coronary artery disease. , 1994, The American journal of cardiology.
[49] P. Hartigan,et al. A Comparison of Angioplasty With Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease , 1992 .
[50] P. Hartigan,et al. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.
[51] R. A. Johnson,et al. Prognostic value of a coronary artery jeopardy score. , 1985, Journal of the American College of Cardiology.
[52] B. Gersh. Effect of PCI on Quality of Life in Patients with Stable Coronary Disease , 2009 .
[53] W. Howard,et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease , 2008 .
[54] M. Escobar,et al. The use of the Tobit model for analyzing measures of health status , 2004, Quality of Life Research.